Literature DB >> 22306104

Evaluation of three different formats of a neutralizing single chain human antibody against toxin Cn2: neutralization capacity versus thermodynamic stability.

Veronica Quintero-Hernández1, Luis Del Pozo-Yauner, Martha Pedraza-Escalona, Victor R Juárez-González, Israel Alcántara-Recillas, Lourival D Possani, Baltazar Becerril.   

Abstract

The single-chain antibody fragment (scFv) 6009F, obtained by directed evolution, neutralizes the effects of the Cn2 toxin, which is the major toxic component of Centruroides noxius scorpion venom. In this work we compared the neutralization capacity and the thermodynamic stability of scFv 6009F with those of two other derived formats: Fab 6009F and diabody 6009F. Additionally, the affinity constants to Cn2 toxin of the three recombinant antibody fragments were determined by means of BIAcore. We found a correlation between the thermodynamic stability of these antibody fragments with their neutralization capacity. The order of thermodynamic stability determined was Fab≫scFv>diabody. The Fab and scFv were capable of neutralizing the toxic effects of Cn2 and whole venom but the diabody was unable to fully neutralize intoxication. In silico analysis of the diabody format indicates that the reduction of stability and neutralization capacity could be explained by a less cooperative interface between the heavy and the light variable domains.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306104     DOI: 10.1016/j.imlet.2012.01.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

Review 1.  Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.

Authors:  Larissa M Alvarenga; Muhammad Zahid; Anne di Tommaso; Matthieu O Juste; Nicolas Aubrey; Philippe Billiald; Julien Muzard
Journal:  Toxins (Basel)       Date:  2014-08-21       Impact factor: 4.546

2.  Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences.

Authors:  Thomas Cnudde; Zineb Lakhrif; Justine Bourgoin; Fanny Boursin; Catherine Horiot; Corinne Henriquet; Anne di Tommaso; Matthieu Olivier Juste; Isabella Gizzi Jiacomini; Isabelle Dimier-Poisson; Martine Pugnière; Marie-Nöelle Mévélec; Nicolas Aubrey
Journal:  Antibodies (Basel)       Date:  2020-04-15

3.  Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.

Authors:  Sabrina Karim-Silva; Alessandra Becker-Finco; Isabella Gizzi Jiacomini; Fanny Boursin; Arnaud Leroy; Magali Noiray; Juliana de Moura; Nicolas Aubrey; Philippe Billiald; Larissa M Alvarenga
Journal:  Toxins (Basel)       Date:  2020-04-16       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.